| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 10 | 2.209 | 648 | 2.751 | 3.568 | 0 | 0 | 0 | 0 | - |
| Total Income - EUR | 10 | 15.124 | 6.637 | 6.819 | 4.443 | 0 | 0 | 0 | 0 | - |
| Total Expenses - EUR | 1.606 | 12.576 | 6.775 | 11.303 | 8.538 | 217 | 0 | 0 | 0 | - |
| Gross Profit/Loss - EUR | -1.596 | 2.548 | -138 | -4.485 | -4.095 | -217 | 0 | 0 | 0 | - |
| Net Profit/Loss - EUR | -1.596 | 2.213 | -289 | -4.690 | -4.228 | -217 | 0 | 0 | 0 | - |
| Employees | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | - |
Check the financial reports for the company - Evotech Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.948 | 3.081 | 1.969 | 892 | 43 | 0 | 0 | 0 | 0 | - |
| Current Assets | 2.367 | 3.021 | 5.891 | 5.430 | 4.596 | 4.508 | 4.409 | 4.422 | 4.409 | - |
| Inventories | 2.209 | 2.871 | 3.236 | 3.893 | 4.595 | 4.508 | 4.408 | 4.422 | 4.409 | - |
| Receivables | 0 | 0 | 58 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Cash | 158 | 150 | 2.597 | 1.537 | 0 | 0 | 0 | 0 | 0 | - |
| Shareholders Funds | -1.551 | 677 | 377 | -4.320 | -8.464 | -8.521 | -8.332 | -8.358 | -8.332 | - |
| Social Capital | 45 | 45 | 44 | 43 | 0 | 0 | 0 | 0 | 0 | - |
| Debts | 5.866 | 5.425 | 7.483 | 10.642 | 13.103 | 13.029 | 12.740 | 12.780 | 12.741 | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4774 - 4774" | |||||||||
| CAEN Financial Year |
8219
|
|||||||||
Comments - Evotech Medical S.r.l.